Department of Psychiatry, Nara Medical University School of Medicine, Kashihara, Japan.
Department of Neuropsychiatry, Kindai University Faculty of Medicine, Osaka, Japan.
Psychiatry Clin Neurosci. 2017 Aug;71(8):554-561. doi: 10.1111/pcn.12523. Epub 2017 May 21.
Both attention-deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) are frequently accompanied by serious aggression that requires psychiatric treatment. However, little is known about the experiences psychiatrists have had using pharmacotherapy to treat aggression in patients who have both ASD and ADHD (ASD/ADHD). The purpose of this study was to examine the experiences of Japanese child and adolescent psychiatrists in prescribing medication for aggression in patients with ASD/ADHD.
A prospective questionnaire was mailed to 2001 psychiatrists affiliated with the Japanese Society for Child and Adolescent Psychiatry. Multivariate logistic regression analysis was used to identify factors predicting the outcome of pharmacotherapeutic treatment of aggression in pediatric and adolescent patients with ASD/ADHD.
Of 2001 psychiatrists, 571 (28.5%) completed the full questionnaire (final sample). Of these, 488 (85.4%) prescribed psychotropic medication in treating pediatric and adolescent patients with ASD/ADHD, 299 (61.3%) of them doing so to treat aggression. Prescribers' duration of practice (odds ratio, 1.055; P = 0.038) and patient symptoms of residual impulsivity (odds ratio, 2.479; P = 0.039) increased the odds of prescribing psychotropic medications to treat aggression in these patients. The respondents reported a similar effect for patients with ADHD/ASD compared with those with ADHD only in treating aggression.
Japanese psychiatrists tended to prescribe psychotropic medication for aggression in pediatric and adolescent patients with ASD/ADHD. Future studies examining aggression in pediatric and adolescent patients with ASD/ADHD should aim to accumulate evidence for the use of psychotropic medications, which could help clinicians make better decisions.
注意缺陷多动障碍(ADHD)和自闭症谱系障碍(ASD)均常伴有严重的攻击行为,需要进行精神科治疗。然而,对于同时患有 ASD 和 ADHD(ASD/ADHD)的患者,精神科医生使用药物治疗攻击行为的经验却知之甚少。本研究旨在考察日本儿童和青少年精神科医生在为 ASD/ADHD 患者开具治疗攻击行为的药物处方方面的经验。
向日本儿童和青少年精神病学会的 2001 名精神科医生邮寄了一份前瞻性问卷。采用多变量逻辑回归分析来确定预测 ASD/ADHD 儿科和青少年患者药物治疗攻击行为结果的因素。
在 2001 名精神科医生中,有 571 名(28.5%)完成了完整的问卷(最终样本)。其中,488 名(85.4%)在治疗 ASD/ADHD 儿科和青少年患者时开具了精神药物,299 名(61.3%)是为了治疗攻击行为。医生的从业年限(比值比,1.055;P=0.038)和患者残留冲动症状(比值比,2.479;P=0.039)增加了为这些患者开具精神药物治疗攻击行为的可能性。受访者报告说,在治疗 ADHD/ASD 患者的攻击行为方面,与仅治疗 ADHD 患者相比,这种效果相似。
日本精神科医生倾向于为 ASD/ADHD 儿科和青少年患者开具治疗攻击行为的精神药物。未来研究应着眼于积累 ASD/ADHD 儿科和青少年患者攻击行为的使用精神药物的证据,这有助于临床医生做出更好的决策。